Citations (34)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Binbin Liu, Pan Su, Peilei Hu, Mi Yan, Wenbin Li, Songlin Yi, Zhenhua Chen, Xiaoping Zhang, Jingwei Guo, Xiaojie Wan, Jue Wang, Daofang Gong, Hua Bai, Kanglin Wan, Haican Liu, Guilian Li & Yunhong Tan. (2024) Prevalence, Transmission and Genetic Diversity of Pyrazinamide Resistance Among Multidrug-Resistant Mycobacterium tuberculosis Isolates in Hunan, China. Infection and Drug Resistance 17, pages 403-416.
Read now
Read now
Sophia B. Georghiou, Margaretha de Vos, Kavindhran Velen, Paolo Miotto, Rebecca E. Colman, Daniela Maria Cirillo, Nazir Ismail, Timothy C. Rodwell, Anita Suresh & Morten Ruhwald. (2023) Designing molecular diagnostics for current tuberculosis drug regimens. Emerging Microbes & Infections 12:1.
Read now
Read now
Jie Shi, Ruyue Su, Danwei Zheng, Yankun Zhu, Xiaoguang Ma, Shaohua Wang, Hui Li & Dingyong Sun. (2020) Pyrazinamide Resistance and Mutation Patterns Among Multidrug-Resistant Mycobacterium tuberculosis from Henan Province. Infection and Drug Resistance 13, pages 2929-2941.
Read now
Read now
Nguyen Quang Huy, Contamin Lucie, Tran Thi Thanh Hoa, Nguyen Van Hung, Nguyen Thi Ngoc Lan, Nguyen Thai Son, Nguyen Viet Nhung, Dang Duc Anh, Bañuls Anne-Laure & Nguyen Thi Van Anh. (2017) Molecular analysis of pyrazinamide resistance in Mycobacterium tuberculosis in Vietnam highlights the high rate of pyrazinamide resistance-associated mutations in clinical isolates. Emerging Microbes & Infections 6:1, pages 1-7.
Read now
Read now
Wanliang Shi, Jiazhen Chen, Jie Feng, Peng Cui, Shuo Zhang, Xinhua Weng, Wenhong Zhang & Ying Zhang. (2014) Aspartate decarboxylase (PanD) as a new target of pyrazinamide in Mycobacterium tuberculosis. Emerging Microbes & Infections 3:1, pages 1-8.
Read now
Read now
Articles from other publishers (29)
Kefan BI, Dan CAO, Cheng DING, Shuihua LU, Hongzhou LU, Guangyu ZHANG, Wenhong ZHANG, Liang LI, Kaijin XU, Lanjuan LI & Ying ZHANG. (2023) The past, present and future of tuberculosis treatment. Journal of Zhejiang University (Medical Sciences) 51:6, pages 657-668.
Crossref
Crossref
Roberto Alcántara, Patricia Fuentes, Lisette Marin, Daniela E. Kirwan, Robert H. Gilman, Mirko Zimic & Patricia Sheen. (2020) Direct Determination of Pyrazinamide (PZA) Susceptibility by Sputum Microscopic Observation Drug Susceptibility (MODS) Culture at Neutral pH: the MODS-PZA Assay. Journal of Clinical Microbiology 58:5.
Crossref
Crossref
Noura M. Al-Mutairi, Suhail Ahmad & Eiman M. Mokaddas. (2019) Molecular characterization of multidrug-resistant Mycobacterium tuberculosis (MDR-TB) isolates identifies local transmission of infection in Kuwait, a country with a low incidence of TB and MDR-TB. European Journal of Medical Research 24:1.
Crossref
Crossref
Kingsley King-Gee Tam, Kenneth Siu-Sing Leung, Gilman Kit-Hang Siu, Kwok-Chiu Chang, Samson Sai-Yin Wong, Pak-Leung Ho, Eunice Ka-Chun Leung & Wing-Cheong Yam. (2019)
Direct Detection of Pyrazinamide Resistance in Mycobacterium tuberculosis by Use of
pncA
PCR Sequencing
. Journal of Clinical Microbiology 57:8.
Crossref
Crossref
Ruwen Jou, Wei-Ting Lee, Elena V. Kulagina, Jui-Yun Weng, Alexandra I. Isakova, Wan-Hsuan Lin, Olga V. Antonova, Mei-Hua Wu, Liaisan R. Arslanbaeva, Hsing-Yuan Tasi, Elena Yu Nosova & Danila V. Zimenkov. (2019) Redefining MDR-TB: Comparison of Mycobacterium tuberculosis clinical isolates from Russia and Taiwan. Infection, Genetics and Evolution 72, pages 141-146.
Crossref
Crossref
Ying Zhang. 2019. Bacterial Resistance to Antibiotics – From Molecules to Man. Bacterial Resistance to Antibiotics – From Molecules to Man
173
199
.
Feng Sun, Yang Li, Yu Chen, Wenlong Guan, Xiangao Jiang, Xiaomeng Wang, Pengfei Ren, Junlian Li, Jichan Shi, Guiqing He, Meiying Wu, Peijun Tang, Fei Wang, Yunfeng Sheng, Fuli Huang, Zumo Zhou, Heqing Huang, Liang Hong, Qihui Liu, Ying Zhang & Wenhong Zhang. (2019) Introducing molecular testing of pyrazinamide susceptibility improves multidrug-resistant tuberculosis treatment outcomes: a prospective cohort study. European Respiratory Journal 53:3, pages 1801770.
Crossref
Crossref
Kwok‐Chiu Chang, Eric Nuermberger, Giovanni Sotgiu & Chi‐Chiu Leung. (2018) New drugs and regimens for tuberculosis. Respirology 23:11, pages 978-990.
Crossref
Crossref
W. Liu, J. Chen, Y. Shen, J. Jin, J. Wu, F. Sun, Y. Wu, L. Xie, Y. Zhang & W. Zhang. (2018) Phenotypic and genotypic characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis clinical isolates in Hangzhou, China. Clinical Microbiology and Infection 24:9, pages 1016.e1-1016.e5.
Crossref
Crossref
Jie Feng, Rebecca Yee, Shuo Zhang, Lili Tian, Wanliang Shi, Wen-Hong Zhang & Ying Zhang. (2018) A Rapid Growth-Independent Antibiotic Resistance Detection Test by SYBR Green/Propidium Iodide Viability Assay. Frontiers in Medicine 5.
Crossref
Crossref
Kwok-Chiu Chang, Wing-Wai Yew & Ying Zhang. (2018) Pyrazinamide Is a Two-Edged Sword: Do WHO Guidelines Matter?. Antimicrobial Agents and Chemotherapy 62:1.
Crossref
Crossref
Yu Pang, Damian Zhu, Huiwen Zheng, Jing Shen, Yan Hu, Jie Liu & Yanlin Zhao. (2017) Prevalence and molecular characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis isolates from Southern China. BMC Infectious Diseases 17:1.
Crossref
Crossref
Jean Claude Semuto Ngabonziza, Awa Ba Diallo, Elisa Tagliani, Bassirou Diarra, Abalo Essosimna Kadanga, Antieme Combo George Togo, Aliou Thiam, Willem Bram de Rijk, Riccardo Alagna, Sabine Houeto, Fatoumata Ba, Anoumou Yaotsè Dagnra, Emil Ivan, Dissou Affolabi, Valérie Schwoebel, Arnaud Trebucq, Bouke Catherine de Jong, Leen Rigouts & Géraldine Daneau. (2017) Half of rifampicin-resistant Mycobacterium tuberculosis complex isolated from tuberculosis patients in Sub-Saharan Africa have concomitant resistance to pyrazinamide. PLOS ONE 12:10, pages e0187211.
Crossref
Crossref
Arfatur Rahman, Sara Sabrina Ferdous, Shahriar Ahmed, S. M. Mazidur Rahman, Mohammad Khaja Mafij Uddin, Suporn Pholwat, Jean Gratz, Eric Houpt & Sayera Banu. (2017)
Pyrazinamide Susceptibility and
pncA
Mutation Profiles of Mycobacterium tuberculosis among Multidrug-Resistant Tuberculosis Patients in Bangladesh
. Antimicrobial Agents and Chemotherapy 61:9.
Crossref
Crossref
Gustavo E. Velásquez, Roger I. Calderon, Carole D. Mitnick, Mercedes C. Becerra, Chuan-Chin Huang, Zibiao Zhang, Carmen C. Contreras, Rosa M. Yataco, Jerome T. Galea, Leonid W. Lecca & Megan B. Murray. (2016) Pyrazinamide Resistance Assays and Two-Month Sputum Culture Status in Patients with Multidrug-Resistant Tuberculosis. Antimicrobial Agents and Chemotherapy 60:11, pages 6766-6773.
Crossref
Crossref
Fatima Osman, Farzana Ismail, Ayman Osman, Shaheed Omar, Halima Said & Nazir Ismail. (2016) High Resolution Melting Curve Analysis for Rapid Detection of Pyrazinamide Resistance in <i>Mycobacterium tuberculosis</i> Clinical Isolates. Journal of Tuberculosis Research 04:04, pages 155-172.
Crossref
Crossref
Shouyong Tan, Yunwei Rao, Jintao Guo, Yaoju Tan, Xingshan Cai, Haobin Kuang, Yanqiong Li, Wenyan Liu, Julius Mugweru, Bangxing Wang, Yuanyuan Cao, Changwei Wang, Ying Zhang & Tianyu Zhang. (2016) The Influence of Pyrazinamide Monoresistance on Treatment Outcomes in Tuberculosis Patients from Southern China. Journal of Tuberculosis Research 04:01, pages 9-17.
Crossref
Crossref
Dawn Verdugo, Dorothy Fallows, Shama Ahuja, Neil Schluger, Barry Kreiswirth & Barun Mathema. (2015) Epidemiologic Correlates of Pyrazinamide-Resistant Mycobacterium tuberculosis in New York City. Antimicrobial Agents and Chemotherapy 59:10, pages 6140-6150.
Crossref
Crossref
Dmitry A. Maslov, Marina V. Zaĭchikova, Larisa N. Chernousova, Kirill V. Shur, Olga B. Bekker, Tatiana G. Smirnova, Elena E. Larionova, Sofya N. Andreevskaya, Ying Zhang & Valery N. Danilenko. (2015) Resistance to pyrazinamide in Russian Mycobacterium tuberculosis isolates: pncA sequencing versus Bactec MGIT 960. Tuberculosis 95:5, pages 608-612.
Crossref
Crossref
X. Gonzalo, F. Drobniewski, S. Hoffner & J. Werngren. (2014) Evaluation of a biphasic media assay for pyrazinamide drug susceptibility testing of Mycobacterium tuberculosis. Journal of Antimicrobial Chemotherapy 69:11, pages 3001-3005.
Crossref
Crossref
S.O. Simons, T. van der Laan, A. Mulder, J. van Ingen, L. Rigouts, P.N.R. Dekhuijzen, M.J. Boeree & D. van Soolingen. (2014) Rapid diagnosis of pyrazinamide-resistant multidrug-resistant tuberculosis using a molecular-based diagnostic algorithm. Clinical Microbiology and Infection 20:10, pages 1015-1020.
Crossref
Crossref
Ying Zhang, Wanliang Shi, Wenhong Zhang & Denis Mitchison. (2014) Mechanisms of Pyrazinamide Action and Resistance. Microbiology Spectrum 2:4.
Crossref
Crossref
Ondrej Jandourek, Martin Dolezal, Jiri Kunes, Vladimir Kubicek, Pavla Paterova, Matus Pesko, Vladimir Buchta, Katarina Kralova & Jan Zitko. (2014) New Potentially Active Pyrazinamide Derivatives Synthesized Under Microwave Conditions. Molecules 19:7, pages 9318-9338.
Crossref
Crossref
Ondrej Jandourek, Martin Dolezal, Pavla Paterova, Vladimir Kubicek, Matus Pesko, Jiri Kunes, Aidan Coffey, Jiahui Guo & Katarina Kralova. (2014) N-Substituted 5-Amino-6-methylpyrazine-2,3-dicarbonitriles: Microwave-Assisted Synthesis and Biological Properties. Molecules 19:1, pages 651-671.
Crossref
Crossref
Heng Li, Jun Chen, Man Zhou, Xuelei Geng, Junping Yu, Weihua Wang, Xian-En Zhang & Hongping Wei. (2014)
Rapid Detection of Mycobacterium tuberculosis and Pyrazinamide Susceptibility Related to
pncA
Mutations in Sputum Specimens through an Integrated Gene-to-Protein Function Approach
. Journal of Clinical Microbiology 52:1, pages 260-267.
Crossref
Crossref
Sven Erik Hoffner. (2013) The role of drug susceptibility testing in M/XDR-TB. Too little and too late – Are we doing the right things?. International Journal of Mycobacteriology 2:4, pages 191-193.
Crossref
Crossref
Kwok-Chiu Chang & Keertan Dheda. (2013) Rationalizing Use of Fluoroquinolones and Pyrazinamide in the Battle against Multidrug-Resistant Tuberculosis. American Journal of Respiratory and Critical Care Medicine 188:1, pages 10-11.
Crossref
Crossref
KWOK ‐CHIU CHANG & WING‐WAI YEW. (2012) Management of difficult multidrug‐resistant tuberculosis and extensively drug‐resistant tuberculosis: Update 2012. Respirology 18:1, pages 8-21.
Crossref
Crossref
Kwok-Chiu Chang, Chi-Chiu Leung, Wing-Wai Yew, Eric Chung-Ching Leung, Wai-Man Leung, Cheuk-Ming Tam & Ying Zhang. (2012) Pyrazinamide May Improve Fluoroquinolone-Based Treatment of Multidrug-Resistant Tuberculosis. Antimicrobial Agents and Chemotherapy 56:11, pages 5465-5475.
Crossref
Crossref